Praseodymium Trifluoromethylsulfonate
965
1
2-(N-Benzylamino)-2-(3-methoxyphenylacetonitrile (entry 5) H NMR
(300 MHz, CDCl3) d 1.84 (br s, 1 H), 3.76 (s, 3 H), 3.95 (AB, q, J ¼ 13 Hz,
2 H), 4.65 (s, 1 H), 6.85 (dd, J ¼ 2.4, 9 Hz, 1 H), 7.14–7.36 (m, 2 H),
7.28–7.43 (m, 6 H); 13C NMR (75 MHz, CDCl3) d 51.6, 53.9, 55.7, 113.4,
114.8, 119.2, 119.8, 128.5, 129.7, 128.8, 130.4, 136.7, 138.6, 160.4; EIMS
m/z 252 (Mþ), 122, 91, 77; HRMS calcd. for C16H16N2O 252.1262,
found 252.1258.
1
2-(N-Benzylamino)-2-furfurylacetonitrile (entry 6) H NMR (300MHz,
CDCl3) d 1.95 (br s, 1 H), 3.94 (AB, q, J ¼ 13 Hz, 2 H), 4.75 (s, 1 H),
6.27–6.32 (m, 1 H), 7.16–7.52 (m, 7 H); 13C NMR (75 MHz, CDCl3) d 47.9,
51.4, 109.2, 111.5, 127.5, 127.8, 128.5, 128.9, 138.2, 143.8, 147.9; EIMS
m/z 212 (Mþ); HRMS calcd. for C13H12N2O 212.0950, found 212.0955.
1
2-(N-Benzylamino)-2-thiophenylacetonitrile (entry 7) H NMR
(300 MHz, CDCl3) d 2.02 (br s, 1 H), 3.96 (AB, q, J ¼ 13Hz, 2 H), 4.91
(s, 1 H), 6.94–6.98 (m, 1 H), 7.21–7.45 (m, 7 H); 13C NMR (75 MHz, CDCl3)
d 49.7, 51.4, 118.4, 126.7, 127.3, 128.3, 128.7, 128.9, 129.2, 138.4, 138.9;
EIMS m/z 228 (Mþ); HRMS calcd. for C13H12N2S 228.0721, found 228.0725.
2-(N-Morpholino)-2-phenylacetontrile (entry 8) 1H NMR (300 MHz,
CDCl3) d 2.51–2.63 (m, 4 H), 4.68–4.79 (m, 5 H), 7.35–7.56 (m, 5 H); 13C
NMR (75 MHz, CDCl3) d 50.4, 62.1, 62.8, 115.7, 128.5, 129.4, 129.8,
133.1; EIMS m/z 202 (Mþ), HRMS calcd. for C12H14N2O 202.1106, found
202.1109.
2-n-Propyl-2-(N-pyrrolidino)acetonitrile
(entry
9) 1H
NMR
(300 MHz, CDCl3) 0.98 (t, J ¼ 7.7 Hz, 3 H), 1.42–1.51 (m, 2 H), 1.69–1.89
(m, 6 H), 2.62–2.71 (m, 4 H), 3.75 (t, J ¼ 7.5 Hz, 1 H); 13C NMR (75 MHz,
CDCl3) d 11.6, 17.4, 21.4, 32.9, 47.9, 53.2, 94.4; EIMS m/z 152 (Mþ),
HRMS calcd. for C9H16N2 152.1313, found 152.1311.
2-(N-furfurylamino)-2-phenylacetonitrile (entry 10) 1H NMR
(300 MHz, CDCl3) 1.82 (br s, 1 H), 4.01 (s, 2 H), 4.79 (s, 1 H), 6.21–6.41
(m, 2 H), 7.31–7.56 (m, 6 H); EIMS m/z 212 (Mþ), 186, 81, 77; HRMS
calcd. for C13H12N2O 212.0949, found 212.0951.
1
2-(N-3-Methoxybenzylamino)-2-phenylacetonitrile (entry 11) H NMR
(300 MHz, CDCl3) d 1.86 (br s, 1 H), 3.81 (s, 3 H), 3.94 (AB, q, J ¼ 13 Hz,
2H), 4.71 (s, 1H), 6.81–6.96 (m, 3H), 7.24 (t, J ¼ 7.8Hz, 1H), 7.30–7.58
(m, 5 H); 13C NMR (75 MHz, CDCl3) 51.4, 53.7, 55.6, 96.6, 113.4, 114.2,
119.1, 120.9, 127.6, 129.4, 130.1, 135.4, 140.1, 160.2; EIMS m/z 252 (Mþ),
122, 91, 77; HRMS calcd for C16H16N2O 252.1262, found 252.1265.
1
2-(N-n-Butylamino)-2-phenylacetonitrile (entry 12) H NMR (300 MHz,
CDCl3) d 0.92 (t, J ¼ 7.2 Hz, 3 H), 1.25–1.47 (m, 4 H), 2.68–2.78 (m, 2 H),
4.74 (s. 1 H), 7.38–7.38 (m, 3 H), 7.65–7.71 (m, 2 H); 13C NMR (75 MHz,
CDCl3) d 14.2, 20.6, 32.3, 47.5, 54.8, 119.4, 127.7, 129.3, 135.5; EIMS
m/z 188 (Mþ); HRMS calcd. for C12H16N2 188.2689, found 188.2693.
2-(N-3,4,5-Trimethoxyanilino)-2-(2,4-dimethoxyphenyl)acetonitrile
(entry 13) 1H NMR (300 MHz, CDCl3) d 3.76 (s, 3 H), 3.81 (s, 3 H), 3.82